| Makerere University College of Health
Sciences_Funding Opportunity Announcements 2022 |
| No. |
FOA
title |
Description |
Funding Amount |
Funding Period |
Funder |
Application
due date |
Letter of
intent due date |
Link |
| 1 |
AFREhealth
Competitive Funding Award call 2022-1 |
The AFREhealth
Secretariat invites competitive applications from African universities to
undertake innovative priority research, training, and education programs
which include the development of evidence-based guidance documents in health
professions education and research relevant to the African context.
Applications that involve more than two AFREhealth universities will be
prioritized. The funding awards are for a project period not exceeding twelve
months at the end of which there should be demonstrable products including at
least one submitted manuscript to a peer-reviewed journal that acknowledges
the funding support. Satisfactory accountability of funds endorsed by one’s
parent institution is an absolute requirement after completion of the project.
For this round, up to 20 competitive applications may be awarded. |
up to 20,000USD |
12 months |
African Forum
for Research and Education in Health |
April 29, 2022 |
11th April 2022 |
https://afrehealth.org/award/notice-of-funding-award |
| 2 |
Translational
Research in Maternal and Pediatric Pharmacology and Therapeutics (R21
Clinical Trial Optional) |
The
purpose of this funding opportunity announcement (FOA) is to encourage
applications that will perform basic, translational and clinical research to
(1) advance the understanding of underlying mechanisms of drug action; (2)
discover and develop novel therapeutics; (3) enhance the usage of existing
drugs or drug repurposing for safer and more effective treatment for pregnant
women, lactating women, neonates and children. The overall goal is to improve
drug safety and efficacy for maternal and pediatric precision therapeutics. |
$275,000 |
2
years |
NIH |
April
11, 2022, August 10, 2022, December 9, 2022 |
30
days prior to application receipt date |
https://grants.nih.gov/grants/guide/pa-files/PAR-20-299.html |
| 3 |
Translational
Research in Maternal and Pediatric Pharmacology and Therapeutics (R01
Clinical Trial Optional) |
The
purpose of this funding opportunity announcement (FOA) is to encourage
applications that will perform basic, translational and clinical research to
(1) advance the understanding of underlying mechanisms of drug action; (2)
discover and develop novel therapeutics; (3) enhance the usage of existing
drugs or drug repurposing for safer and more effective treatment for pregnant
women, lactating women, neonates and children. The overall goal is to improve
drug safety and efficacy for maternal and pediatric precision therapeutics. |
Application budgets are not limited |
5
years |
NIH |
April
11, 2022, August 10, 2022, December 9, 2022 |
30
days prior to application receipt date |
https://grants.nih.gov/grants/guide/pa-files/PAR-20-300.html |
| 4 |
Request
for Proposal: Impact of Policies and Regulations on Tobacco Harm Reduction in
Low- and Middle-Income Countries (LMICs) |
This
RFP seeks to support independent research that has the potential to build on
the current evidence base and improve smoker outcomes in areas of unmet need
that are aligned with the Foundation’s strategy. |
USD 400,000 |
8
months |
Foundation
for a Smoke -Free World (FSFW) |
16-May-22 |
Not
applicable |
https://www.smokefreeworld.org/ |
| 5 |
Upcoming:
Applied global health research |
The
applied global health research board supports applied research that will be
of direct and primary benefit to the health of vulnerable populations. We’re
looking for research projects that will develop practical solutions to health
challenges. This includes:late-stage intervention development
global health trials
implementation and scale-up research
health systems research
health economics
health policy research
research with a predominantly applied focus that does not fit within the
remit of other MRC boards and panels. |
£1 million |
Not
specified |
Medical
Research Council (MRC) |
28-Jul-22 |
Not
applicable |
https://www.ukri.org/opportunity/applied-global-health-research/ |
| 6 |
Wellcome
Early-Career Awards |
This
scheme provides funding for early-career researchers from any discipline who
are ready to develop their research identity. Through innovative projects,
they will deliver shifts in understanding that could improve human life,
health and wellbeing. By the end of the award, they will be ready to lead
their own independent research programme. |
£400,000 |
5
years |
Wellcome
Trust |
21-Jun-22 |
Not
applicable |
https://wellcome.org/grant-funding/schemes/early-career-awards |
| 7 |
Wellcome
Career Development Awards |
This
scheme provides funding for mid-career researchers from any discipline who
have the potential to be international research leaders. They will develop
their research capabilities, drive innovative programmes of work and deliver
significant shifts in understanding that could improve human life, health and
wellbeing. |
Application
budgets are not limited |
8
years |
Wellcome
Trust |
21-Jul-22 |
Not
applicable |
https://wellcome.org/grant-funding/schemes/career-development-awards |
| 8 |
Wellcome
Discovery Awards |
This
scheme provides funding for established researchers and teams from any
discipline who want to pursue bold and creative research ideas to deliver
significant shifts in understanding that could improve human life, health and
wellbeing. |
Application
budgets are not limited |
8
years |
Wellcome
Trust |
26-Jul-22 |
Not
applicable |
https://wellcome.org/grant-funding/schemes/discovery-awards |
| 9 |
Mental
Health Award: looking backwards, moving forward – understanding how
interventions for anxiety, depression, and psychosis work |
This
call provides funding for teams of researchers working across any discipline
of relevance to mental health science. They will investigate the causal
mechanisms underpinning effective interventions for anxiety, depression,
and/or psychosis, to inform the development of new and improved early
interventions. |
Up
to £5 million |
8
years |
Wellcome
Trust |
24-May-22 |
Not
applicable |
https://wellcome.org/grant-funding/schemes/mental-health-award-interventions-anxiety-depression-psychosis |
| 10 |
Mental
Health Award: improving cognitive and functional outcomes in people
experiencing, or at risk of, psychosis |
This
call will provide funding to individuals or teams from not-for-profit or
commercial organisations for two types of applications. Firstly, to develop
and evaluate interventions to improve cognitive and functional outcomes for
people experiencing, or at risk of, psychosis. Secondly, to test new or
existing markers of cognitive functioning for prediction of risk or treatment
stratification. |
Up to £3 million |
Up
to 5 years |
Wellcome
Trust |
05-May-22 |
Not
applicable |
https://wellcome.org/grant-funding/schemes/improving-cognitive-and-functional-outcomes-psychosis |
| 11 |
Heat
adaptation: evaluating interventions to help manage the health effects of
heat |
The
award will fund teams led by researchers from low- or middle-income countries
(LMIC) to test interventions to manage heat-related health risks in real
settings – not under laboratory conditions. By the end of the award,
successful applicants will have delivered a high-quality study testing and
evaluating a new or existing heat adaptation intervention with the potential
to change policy and practice in LMICs. |
Between £500,000 and £2 million |
Up
to 5 years |
Wellcome
Trust |
31st
May 2022 |
Not
applicable |
https://wellcome.org/grant-funding/schemes/heat-adaptation-evaluating-interventions-help-manage-health-effects-heat |
| 12 |
Digital
Technology Development Awards (Climate-Sensitive Infectious Disease
Modelling) |
This
one-off call provides funding for software developers from any career stage
and discipline to develop digital tools that will improve climate-sensitive
infectious disease modelling. By the end of the award, successful applicants
will have delivered a piece of open-source digital technology that will
increase the impact of research in addressing this threat to health. |
Up to £500,000 |
Up
to 5 years |
Wellcome
Trust |
May-22 |
Not
applicable |
https://wellcome.org/grant-funding/schemes/digital-technology-development-awards-climate-sensitive-infectious-disease |
| 13 |
Henipavirus
– Request for proposals 2022 |
This
RfP will support projects that seek to elucidate the molecular determinants
of henipavirus replication, pathogenesis and transmission for the purpose of
developing therapeutic discovery programs targeting virus and/or
host-specific targets important for virus replication. Projects can be of
both novel and exploratory nature and of later-stage validation/developmental
nature. |
USD 10 million |
3
years |
Pandemic
Antiviral discovery |
5
May 2022, |
Not
applicable |
https://padinitiative.com/henipavirus-request-for-proposals-2022/ |
| 14 |
NIDCR
Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed) |
This
NIDCR Small Grant Program for New Investigators supports basic and clinical
research conducted by scientists who are in the early stages of establishing
an independent research career in oral, dental and craniofacial research.
This R03 program supports pilot or feasibility studies and developmental
research projects with the intention of obtaining sufficient preliminary data
for a subsequent investigator initiated Research Project Grant (R01) or
equivalent application. |
$200,000 |
two
years |
NIH |
June
16 2022, October 16 2022 |
Not
applicable |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-084.html |
| 15 |
Research
Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical
Trial Not Allowed) |
Through
this Funding Opportunity Announcement (FOA), the National Cancer Institute
(NCI) encourages grant applications to support research in established cancer
epidemiology cohort studies, defined as studies that have achieved their
initial planned recruitment goal. Applications must include hypothesis-based
research using data from an established cohort study and are expected to
include support for cohort maintenance, continued follow-up, and sharing of
the existing resources in addition to addressing research questions across
the cancer control continuum. |
Application budgets are not limited |
5
years. |
NIH |
July
29, 2022 |
Not
applicable |
https://grants.nih.gov/grants/guide/pa-files/PAR-22-162.html |
| 16 |
Implementation
Research to Reduce Noncommunicable Disease (NCD) Burden in Low- and
Middle-Income Countries (LMICs) and Tribal Nations During Critical Life
Stages and Key Transition Periods (R01 Clinical Trial Optional) |
This
Funding Opportunity Announcement (FOA) supports innovative approaches to
identifying, understanding, developing, and implementing strategies for
overcoming barriers to the adoption, adaptation, integration, scale-up, and
sustainability of evidence-based interventions, tools, policies, and
guidelines. In addition, studies to advance dissemination and implementation
research methods and measures into application are encouraged. Specifically,
this FOA invites applications that propose interventions targeting critical
life stages (e.g., infancy, childhood, adolescence, pregnancy, older adults)
and key transitions between life stages to reduce health risk and/or enhance
positive health and lifestyle behaviors. |
Application budgets are not limited |
5
years |
NIH |
July
27, 2022 |
30
days before receipt date |
https://grants.nih.gov/grants/guide/pa-files/PAR-22-132.html |
| 17 |
Partnerships
for the Development of Novel Therapeutics to Combat Select Antibiotic
Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed) |
The
purpose of this Funding Opportunity Announcement (FOA) is to solicit research
applications for milestone-driven projects focused on preclinical development
of lead candidate therapeutics and related countermeasures against antibiotic
resistant Acinetobacter baumannii, Pseudomonas aeruginosa,
Enterobacteriaceae, or Candida auris. Applications must include a Product
Development Strategy attachment. Substantive investment by industrial
participants is highly encouraged. |
$650,000 per year |
5
years. |
NIH |
July
29, 2022 |
30
days prior to the application due date |
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-22-028.html |
| 18 |
Laboratories
to Optimize Digital Health (R01 Clinical Trial Required) |
NIMH
seeks applications for innovative research projects to test strategies to
increase the reach, efficiency, effectiveness, and quality of digital mental
health interventions which may impact mental health outcomes, including
suicide behaviors and serious mental illness. This Funding Opportunity
Announcement (FOA) is intended to support the development of digital health
test beds that leverage well-established digital mental health platforms and
infrastructure to rapidly refine and optimize existing evidence-based digital
health interventions and to conduct clinical research testing digital mental
health interventions that are statistically powered to provide a definitive
answer regarding the intervention’s effectiveness particularly in populations
who experience health disparities and vulnerable populations. |
Application budgets are not limited |
4
years. |
NIH |
June
05, 2022, October 05, 2022, February 05, 2023 |
30 days prior to the application due date |
https://grants.nih.gov/grants/guide/pa-files/PAR-22-154.html |
| 19 |
E.W.
“Al” Thrasher
Awards |
The
purpose of the E.W. “Al” Thrasher Awards is
to improve children’s health through medical
research, with an emphasis on projects that have
the potential to translate into clinically
meaningful results within a few years. The Fund
awards grants two times per year, with no fixed
number of awards given in each funding cycle or
in each year. |
$370,000 |
3
years |
Thrasher
Research Fund |
October
28, 2022 |
July
19, 2022 |
https://www.thrasherresearch.org/al-thrasher-award?lang=eng |
| 20 |
TB
REACH WAVE
10 CALL FOR
PROPOSALS IS
NOW OPEN
First Time Ever
Funding for
Integrated
Service Delivery
or Expansion of
TB Preventive
Treatment |
Stop
TB Partnership’s TB REACH initiative
announced today its Wave 10 Call for Proposals,
seeking bold and innovative strategies that will
help the fight to end tuberculosis (TB) while
simultaneously contributing to health systems
strengthening (HSS). It is the first time that a
granting mechanism call for proposals focused
on these two new areas: Integrating TB Service
Delivery and/or TB Preventive Treatment. |
Not Specified |
Not
specified |
Stop
TB
Partnership’s TB
REACH.
Contributions
from Global
Affairs Canada,
UK Foreign,
Commonwealth &
Development
Office (FCDO) and
USAID |
11-May-22 |
Not
applicable |
https://www.stoptb.org/news/tb-reach-wave-10-call-proposals-is-now-open |
| 21 |
Tackling
diseases (Single Stage – 2022) (HORIZON-HLTH-2022-DISEASE-07) Non-communicable diseases risk
reduction in adolescence and youth (Global Alliance for Chronic Diseases –
GACD) |
This
topic aims at supporting activities that are enabling or contributing to one
or several expected impacts of destination 3 “Tackling diseases and reducing
disease burden”. To that end, proposals under this topic should aim for
delivering results that are directed, tailored towards and contributing to
some of the following expected outcomes:
Health care practitioners and providers in low- and middle-income countries
(LMICs) and those in high-income countries (HICs) serving vulnerable
populations have access to and use specific guidelines to implement
prevention interventions able to support adolescents and young people to
decrease future risks of developing NCDs. |
€25 000 000 |
Not
specified |
European
Commission |
21-Apr-22 |
Not
Applicable |
https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-hlth-2022-disease-07-03 |
| 22 |
Pandemic
preparedness – HORIZON-HLTH-2022-DISEASE-07-02 |
This
topic aims at supporting activities that are enabling or contributing to one
or several expected impacts of destination 3 “Tackling diseases and reducing
disease burden under this topic should aim for delivering results that are
directed, tailored towards and contributing to some of the following expected
outcomes:
The scientific community has better understanding of the biology of the
pathogens (virus, bacteria etc.), its transmission, its interaction with
humans, animals and plants, in particular in view of emerging threats to
human health, such as infectious diseases and anti-microbial
resistance. |
€
10,000,000 |
Not
specified |
European
Commission |
21-Apr-22 |
Not
Applicable |
https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-hlth-2022-disease-07-02 |
| 23 |
Pre-announcement:
Public Health Intervention Development (PHIND): Sep 2022 |
MRC
is looking to support the early-stage development of interventions that seek
to address either UK or global public health challenges.This might include qualitative and quantitative primary research and the
development of theory and logic models. However, emphasis should be placed on
developing the intervention.
This opportunity supports the incorporation of systems thinking when
addressing public health challenges. It is justifiable to focus on just one
aspect of a system, as long as the wider systems context is recognised. For
example, in the framework for evaluation.
It also encourages the use of multi-disciplinary teams and co-production
with users and other relevant stakeholders, such as policy makers. |
£150,000 |
Not
specified |
Medical
Research Council (MRC) |
Closing
date: To be confirmed |
Not
Applicable |
https://www.ukri.org/opportunity/public-health-intervention-development/?utm_medium=email&utm_source=govdelivery |
| 24 |
Enhancing
Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and
Support Recovery (R34 – Clinical Trial Optional) |
The
National Institutes of Health (NIH) is inviting applications for this
planning grant. This Funding Opportunity Announcement (FOA) encourages pilot
work and preliminary research to support preparation for large-scale,
rigorous trials examining strategies to address social connectedness and/or
loneliness in order to prevent or treat SUDs or enhance recovery. The goal of
this FOA is to develop user-centered interventions addressing social
connectedness and loneliness in the context of substance use that is
effective, practical, cost-effective, scalable, and sustainable. |
USD 450,000 |
3
years |
National
Institute of Health (NIH) |
15-Aug-22 |
Not
applicable. |
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-010.html |
| 25 |
Enhancing
Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and
Support Recovery (R21 – Clinical Trial Not Allowed) |
The
National Institutes of Health (NIH) is inviting applications for an
Exploratory/Developmental Research Grant. This Funding Opportunity
Announcement (FOA) encourages exploratory and developmental research to
better understand the role of social connectedness and/or loneliness in
prevention, treatment, and recovery from substance use disorders (SUDs).
Research may use a variety of approaches, including leveraging existing data
sources, survey research, social network analysis, new methods development,
feasibility research, etc. Outcomes of interest include any of the following:
substance use initiation, escalation, SUD diagnosis, connection to treatment,
and engagement or retention in treatment or recovery. |
USD 275,000 |
2
years |
National
Institute of Health (NIH) |
August
15, 2022 |
Not
applicable. |
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-009.html |
| 26 |
Wellcome
Mental Health Data Prize |
The
Wellcome Data Prize in mental health will support collaborative approaches to
research into anxiety and depression in young people. Teams in the UK and
South Africa will explore existing data to find new insights and build
digital tools that enable future research. Data prizes are an open
competition or challenge where participants use data to solve a societal
problem. A key aim of this prize is to build a multidisciplinary mental
health data community by bringing together people with mental health research
backgrounds and data expertise. By mental health science, they mean any
discipline that uses evidence in rigorous and transparent ways, whether based
on observation or experimentation. This could include: psychiatry,
psychology, neuroscience, and disciplines within the humanities, social
sciences, and computer sciences, among others |
British Pounds 500,000 |
Not
applicable |
Wellcome
trust |
30-Jun-22 |
Not
applicable. |
https://wellcome.org/grant-funding/schemes/wellcome-mental-health-data-prize#how-to-apply-988d |
| 27 |
Covid-19:
understanding the biological significance of SARS-CoV-2 variants |
This
call is for research into the biological significance of SARS-CoV-2 variants,
focused on laboratory investigations in immunology, virology, or structural
biology. The goal is to produce research that is relevant and beneficial to
low- and middle-income countries. The research must support national
policymakers in preventing and controlling the Covid-19 pandemic and should
strengthen capability in low- and middle-income countries for a research
response to future infectious disease outbreaks. Applicants should consider
how to involve and respond to the needs and concerns of relevant public
stakeholders and facilitate an open and transparent environment to ensure the
research is trustworthy, acceptable to, and supported by relevant
communities. |
British Pounds 3,000,000 |
3
years |
Wellcome
trust |
28-Apr-22 |
Not
applicable. |
https://wellcome.org/grant-funding/schemes/covid-19-understanding-biological-significance-sars-cov-2-variants#key-dates-1431 |
| 28 |
New
Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure
(R01 Clinical Trial Not Allowed) |
The
purpose of this Funding Opportunity Announcement (FOA) is to support research
on the development and validation of innovative strategies to deliver
anti-HIV gene therapies efficiently to specific target cells in vivo. |
Application budgets are not limited |
5
years. |
National
Institute of Health (NIH) |
March
17, 2023 |
30
days prior to the application due date |
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-20-076.html |
| 29 |
Doctoral
Dissertation Grants |
The 2022 DDG competition and funding is intended to support worthy
applicants who have advanced to candidacy (i.e., the dissertation phase) in
their doctoral programs and whose dissertation research plans address TIRF’s
Research Priorities |
USD 5,000 |
Not
Applicable |
International
Research Foundation for English Language Education (TIRF) |
18-May-22 |
Not
Applicable |
https://www.tirfonline.org/doctoral-dissertation-grants/ |
| 30 |
Early
Career Awards |
The
Fund recognizes that young investigators may find it difficult to remain in
pediatric research because of a lack of funding. Thus, the purpose of this
program is to encourage the development of medical research in child health
by awarding small grants to new researchers, helping them gain a foothold in
this vital area. The goal is to fund applicants who will go on to be
independent investigators. The Fund is open to a wide variety of research
topics and does not focus on a particular disease, but all our funded
projects deal directly with children’s health. In the Early Career Award
Program, the Fund is particularly interested in applicants that show
significant potential to impact that field of children’s health through
medical research. |
USD 25,000 |
1-2
years |
Thrasher
Research Fund |
13-Sep-22 |
Not
Applicable |
https://www.thrasherresearch.org/early-career-award?lang=eng |
| 31 |
Scaling
up of cells and stacks for large electrolysers |
This
topic concerns the research and development of much larger cells and stacks
for water electrolyzers than the current State of the Art (SoA). By upscaling
electrolyzer cells and stacks, economies of scale can be realized in
manufacturing and more compact installations can be achieved when integrating
electrolyzers into industrial chemical processes, thermal processes, and
hydrogen hubs. The application of electrolyzers to industrial clusters and
hydrogen hubs in order to achieve substantial CO2 savings is inhibited by the
present capacities of electrolyzer stacks. Hydrogen production could be
achieved more cost-effectively if larger electrolyzer cells and stacks were
available. When compared with the current SoA, the development of an
electrolyzer module of about 10MW, if feasible, would be a considerable step
forward (where a module comprises the least number of stacks and preferably
only one stack). |
EURO 121,000,000 |
Not
specified |
European
Commission |
20-Sep-22 |
Not
Applicable |
https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-jti-cleanh2-2022-01-05;callCode=HORIZON-JTI-CLEANH2-2022-2;freeTextSearchKeyword=;matchWholeText=true;typeCodes=1;statusCodes=31094501,31094502,31094 |
| 32 |
HIV
Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) |
The
purpose of this Funding Opportunity Announcement (FOA) is to support
multi-component, multi-disciplinary projects that address scientific
questions relevant to AIDS prophylactic vaccine discovery research. Extensive
evaluation of vaccine concepts in non-human primate models may be
included. |
USD 2,500,000 |
5
years |
National
Institute of Health (NIH) |
15-Mar-23 |
Not
Applicable |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-024.html |
| 33 |
Extracellular
RNA carrier subclasses in processes relevant to Substance Use Disorders or
HIV infection (R21- Clinical Trial Not Allowed) |
The
purpose of this FOA is to encourage research investigating the roles of
extracellular RNA (exRNA) carrier subclasses in biological processes relevant
to substance use disorders (SUDs) and/or HIV infection, latency, or
pathogenesis in the CNS. Applicants may propose to investigate biological
mechanisms involving exRNA carrier subclasses, or propose to develop improved
technologies to investigate extracellular vesicles or other exRNA carriers. |
USD 275,000 |
2
years |
National
Institute of Health (NIH) |
13-Oct-22 |
Not
Applicable |
https://grants.nih.gov/grants/guide/pa-files/par-20-147.html |
| 34 |
Jorma
Ollila Grant |
The
Jorma Ollila special fund was created to support recently graduated doctors
to further develop their research careers. These personal grants are awarded
for the purpose of gaining international experience and research excellence
for a period of 1-3 years. In addition to financial support, the new special
fund will support the selected applicants through the contact network of the
Nokia Foundation. |
20 000 € |
1-3
years |
Nokia
Foundation |
22-Sep-22 |
Not
Applicable |
http://nokiafoundation.com/grants/jorma-ollila-grant/ |
| 35 |
Real
World Experience with Biosimilar Medicines in Oncology |
Pfizer
Global Medical Grants (GMG) supports the global healthcare community’s
independent initiatives to improve patient outcomes in areas of unmet medical
need that are aligned with Pfizer’s medical and/or scientific strategies.
Medical education projects that will be considered for this Pfizer grant
support will focus on increasing the awareness and understanding of
real-world experience with oncology monoclonal antibody biosimilars and the
health economic considerations of biosimilars to providers, patients, and
stakeholders. There is an emerging body of real-world data on biosimilars
that were previously lacking. The goal of this RFP is to apply and convey the
retrospective body of real-world data in oncology biosimilars to enhance
understanding of real-world experiences, including implementation, switching,
and health economics. Of particular interest are biosimilars used in the
treatment of lymphoma, colorectal and lung cancer, and breast cancer |
$450,000 |
18
months |
Pfizer
Inc |
10-May-22 |
Not
Applicable |
https://cdn.pfizer.com/pfizercom/2022-03/GMG_2022-Onc-Global_RealWorldExperienceBiosimilarMedicinesOncology.pdf?C9V1VqACeRmpHpy1.LGyl55lwwYyc8io |
| 36 |
ISEG
Postgraduate Training Fellowship in Medical Statistics for African Scientists |
The
International Statistics and Epidemiology Group( ISEG )Postgraduate Training
Fellowship in Medical Statistics for African Scientists launched in 2005 and
forms a key part of ISEG’s investment in capacity strengthening. Two
fellowships are available, funded by the UK Medical Research Council (MRC)
and the Faculty of Epidemiology and Population Health at LSHTM, to provide
support for two years of training in medical statistics. For the first year,
the successful applicants will study for the MSc degree in Medical Statistics
at the London School of Hygiene & Tropical Medicine (LSHTM). This will be
followed by a one-year professional attachment at one of the African centres
associated with the research programme of the MRC International Statistics and
Epidemiology Group (ISEG) at LSHTM. During the professional attachment,
training Fellows will develop their statistical and research skills by
working on studies with guidance from ISEG scientists. This is intended to
foster excellence in the field of medical statistics and epidemiology in
sub-Saharan Africa. |
Not
Specified |
Not
specified |
London
School of Hygiene & Tropical Medicine |
15-Apr-22 |
Not
Applicable |
https://www.lshtm.ac.uk/research/centres-projects-groups/mrc-international-statistics-and-epidemiology-group#fellowships |
| 37 |
African
Guest Researchers’ Scholarship Programme |
The
purpose of the African Guest Researchers’ Scholarship Programme is to provide
opportunities for postdoctoral researchers based in Africa to work and
develop their ongoing research at the Nordic Africa Institute. The
scholarship offers access to the Institute’s library and other resources that
provide for a stimulating research environment. Through the programme, the
Nordic Africa Institute aims to contribute to building capacity in the
production of knowledge about Africa and to promote and establish relations
with and between African and Nordic research communities. |
Not Specified |
90
days |
Nordic
Africa Institute |
01-May-22 |
Not
Applicable |
https://nai.uu.se/opportunities/scholarships/african-guest-researchers-scholarship-programme.html |
| 38 |
Google
PhD Fellowship Program – Africa |
Google
PhD Fellowships directly support graduate students as they pursue their PhD,
as well as connect them to a Google Research Mentor. Nurturing and
maintaining strong relations with the academic community is a top priority at
Google. The Google PhD Fellowship Program was created to recognize
outstanding graduate students doing exceptional and innovative research in
areas relevant to computer science and related fields. Fellowships support
promising PhD candidates of all backgrounds who seek to influence the future
of technology. Google’s mission is to foster inclusive research communities
and encourage people of diverse backgrounds to apply. They currently offer
Fellowships in Africa, Australia, Canada, East Asia, Europe, India, New
Zealand, Southeast Asia and the United States. |
Not Specified |
Not
specified |
Google |
27-Apr-22 |
Not
Applicable |
https://research.google/outreach/phd-fellowship/ |
| 39 |
Modular
R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) |
This
funding opportunity announcement (FOA) encourages applications for research
in cancer control and population sciences. The overarching goal is to provide
support to promote research efforts on novel scientific ideas that have the
potential to substantially advance cancer research in statistical and
analytic methods, epidemiology, cancer survivorship, cancer-related behaviors
and behavioral interventions, health care delivery, and implementation
science. |
USD 250,000 per year |
5
years |
National
Institute of Health (NIH) |
08-Nov-22 |
Not
Applicable |
https://grants.nih.gov/grants/guide/pa-files/PAR-18-869.html |
| 40 |
Partnerships
for Rapid Diagnostics and Phenotypic Antibacterial Susceptibility Testing for
Bacteremia or Hospital Acquired Pneumonia (R01 Clinical Trial Not Allowed) |
The
purpose of this Funding Opportunity Announcement (FOA) is to support research
projects focused on development and/or production of medical diagnostics that
permit rapid differential species identification, and corresponding
phenotypic antibacterial susceptibility profiles for bacteremia or hospital
acquired pneumonia. The primary goal of such diagnostics is to facilitate
antibacterial stewardship, thereby reducing selective pressure and improving
patient outcomes. |
up to $500,000 per year |
5
years |
National
Institutes of Health (NIH)National Institute of Allergy and Infectious Diseases (NIAID) |
June
01, 2022 |
30
days prior to the application due date |
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-22-010.html |
| 41 |
HORIZON-HLTH-2022-DISEASE-07 Support for the functioning of the Global
Research Collaboration for Infectious Disease Preparedness (GloPID-R) |
This
topic aims at supporting activities that are enabling or contributing to one
or several expected impacts of destination 3 “Tackling diseases and reducing
disease burden”. To that end, proposals under this topic should aim for
delivering results that are directed, tailored towards and contributing to
some of the following expected outcomes:
International research funders are supported by a dynamic and efficient
secretariat in their coordination efforts for a rapid research response when
a pandemic or a severe epidemic strikes.
International research funders can rely on a tested framework underpinning
a rapid and effective research response, and as such ensure stronger research
preparedness and response for public health emergencies, including in
cross-cutting areas such as data sharing, social science, clinical trial
networks and others.
Research funders, policy makers and the research community are well
informed of the activities of GloPID-R members, both as a group and individually. |
€
2,000,000 |
Not
specified |
European
Commission |
21-Apr-22 |
Not
Applicable |
https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-hlth-2022-disease-07-01 |
| 42 |
Women
RISE: Research to support women s health and economic empowerment for a
COVID-19 Recovery that is Inclusive, Sustainable and Equitable |
This
call for proposals will be available to fund research teams conducting
action-oriented, gender-transformative research projects to understand the
relationships between women’s work and health before, during, and after
COVID-19. Specifically, this funding opportunity will support population
and public health research in LMICs that addresses UN Research Roadmap
Priority 3.5: “How have recent economic changes disproportionately impacted
women and how can recovery strategies be inclusive and gender-transformative?”? |
CAD
1,000,000 |
24
months |
International
Development Research Center(IDRC) |
Jul-22 |
April
2022 |
https://idrc.ca/en/upcoming-funding-opportunity-women-rise-research-support-womens-health-and-economic-empowerment?utm_source=Funding+Alerts&utm_campaign=059ff0c775-EMAIL_CAMPAIGN_7_31_2020_9_57_COPY_01&utm_medium=email&utm_term=0_02f2dae0ce-059ff0c775-95 |
| 43 |
Pre-announcement: Turing AI
World-Leading Researcher Fellowships: rounds two and three |
Research
should show significant novelty in the development of AI technologies and
should go beyond applying established AI approaches within applications. |
Not
specified |
Not
specified |
UK
Research and Innovation |
To
be confirmed |
Not
applicable |
https://www.ukri.org/opportunity/turing-ai-world-leading-researcher-fellowships-rounds-two-and-three/?utm_medium=email&utm_source=govdelivery |
| 44 |
Apply
for MSc programs |
MSc
programs for 2022-2023 academic year |
Not
Specified |
Depends
on the programme |
Skolkovo
Institute of Science and Technology (Skoltech) |
10-Jul-22 |
Not
applicable |
https://www.skoltech.ru/en/apply/msc-programs/ |
| 45 |
Lipids
in Brain Aging and Alzheimers Disease (AD) and its Related Dementias (ADRD)
(R01 Clinical Trial Not Allowed) |
The
goal of this Funding Opportunity Announcement (FOA) is to support
research addressing critical knowledge gaps in our understanding of how
lipids contribute to vulnerability and resilience to brain aging and
Alzheimer’s disease (AD) and its related dementias (ADRD) |
$500,000 |
5
years |
National
Institutes of Health (NIH) |
June
14, 2022 |
May
15, 2022 |
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-009.html |
| 46 |
Social
disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) |
The
purpose of this FOA is to encourage research that addresses the link between
social disconnection in late-life and late-life suicidal thoughts and
behaviors. Of specific interest is research that identifies mechanisms by
which social disconnection confers risk for, and social integration protects
against, suicidal thoughts and behaviors in late life. |
Application
budgets are not limited |
5
years |
National
Institutes of Health (NIH) |
October
15, 2022 |
30
days prior to the application due date |
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-135.html |
| 47 |
Global
Masters Scholarship |
The
University of Birmingham invites applications for Global Masters Scholarship.
Birmingham has a proud heritage of removing barriers to education to enable
the most academically talented students to fulfil their potential in learning
and education. In keeping with this tradition, they are proud to be
launching the Global Masters Scholarship to attract and support the most
academically talented international students from across the world to their
Master’s degrees during the 2022/23 academic year. |
British
Pounds 10,000 |
Depends
on the programme |
University
of Birmingham |
30-Jun-22 |
Not
applicable |
https://www.birmingham.ac.uk/postgraduate/funding/global-masters-scholarship.aspx |
| 48 |
Cancer
Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered
Technologies for Cancer Research (R01 Clinical Trial Optional |
This
Funding Opportunity Announcement (FOA) will support the development and
characterization of state-of-the-art biomimetic tissue-engineered
technologies for cancer research. Collaborative, multidisciplinary projects
that engage the fields of regenerative medicine, tissue engineering,
biomaterials, and bioengineering with cancer biology will be essential for
generating novel experimental models that mimic cancer pathophysiology in the
context of a testable cancer research hypothesis |
$400,000
per year |
5
years |
National
Institutes of Health (NIH) |
June
05, 2022, October 05, 2022 |
30
days prior to the application due date |
https://grants.nih.gov/grants/guide/pa-files/PAR-22-099.html |
| 49 |
A
life course approach to common NCD risk factor prevention and reduction |
The
GACD seeks to fund collaborative, multidisciplinary and cross-cultural teams.
The teams should include appropriate expertise in implementation research.
Other eligibility requirements differ for each funding agency, and can be
found in the agency-specific information listed on this page. Research should
aim to improve health equity in low- and middle-income countries (LMICs) or
among disadvantaged populations in high-income countries (HICs) |
EUR 25,000,000 |
not
spceified |
European
Commission (EC) |
31-May-22 |
Not
applicable |
https://www.gacd.org/news/2021-11-30-gacd-announces-new-funding-call#:~:text=In%20the%20context%20of%20this,long%20and%20potentially%20intergenerational%20health. |
| 50 |
Reducing
global health non-communicable disease risk for young people |
Apply
for global health funding to reduce the risk of non-communicable diseases
through implementation research.You must:
be based at a UK research organisation eligible for UKRI funding
work in partnership with co-investigators based in low or middle income
countries (LMICs) where the work will take place.
Your research must:
take a life course approach
focus on people aged 10 to 24 in LMICs. |
£5,000,000 |
five
years |
Medical
Research Council |
31-May-22 |
19-Apr-22 |
https://www.ukri.org/opportunity/reducing-global-health-non-communicable-disease-risk-for-young-people/ |
| 51 |
International
Capacity Building Fund |
The
purpose of the International Capacity Building (ICB) Fund is to provide
resources to enhance education and training of applied microbiology in
developing countries. |
British Pounds 5,000 |
Not
specified |
Society
for Applied Microbiology |
Throughout
the year. |
Not
Applicable |
https://sfam.org.uk/career/grants/international-capacity-building-fund.html |
| 52 |
Clinical
Studies of Mental Illness (Collaborative R01 Clinical Trial Optional) |
This
Funding Opportunity Announcement (FOA) seeks to support collaborative
clinical studies, not involving treatment development, efficacy, or
effectiveness trials. |
not limited |
5
years |
NIH |
September
07, 2022 |
Not
applicable |
https://grants.nih.gov/grants/guide/pa-files/PAR-19-297.html |
| 53 |
OPTions
Initiative – Next-Generation Methods |
Seed
grants are available for innovations that seek to test and develop
next-generation methods of pregnancy termination, menses induction, or
conception interruption |
$250,000 to $400,000 CAD |
18
to 24 months |
Grand
Challenges Canada |
Rolling
basis until December 31,2022 |
Not
applicable |
https://www.grandchallenges.ca/funding-opportunities/ |
| 54 |
Planning
Grant for Global Infectious Disease Research Training Program (D71 –
Clinical Trials Not Allowed) |
The
application should propose a collaborative process to create a new training
program that will strengthen the capacity of the LMIC institution to conduct
infectious disease research |
$100,000 (total direct costs) per year |
2
years |
NIH |
October
28, 2022 |
September
28, 2021 |
https://grants.nih.gov/grants/guide/pa-files/PAR-19-362.html# |
| 55 |
Innovations
in HIV Prevention, Testing, Adherence and Retention to Optimize HIV
Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional) |
This
Funding Opportunity Announcement (FOA) seeks innovative research to optimize
HIV prevention and care which is aligned with NIMH Division of AIDS Research
(DAR) priorities. Applications may include formative basic behavioral and
social science to better understand a step or steps in the HIV prevention or
care continuum, and/or the initial development and pilot testing of
innovative intervention approaches. Applicants are encouraged to read current
Notices of Special Interests (NOSIs) from NIMH DAR for further information
about the Division’s research priorities. |
up to $275,000 |
2
years |
NIH |
October
16 2022 |
Not
applicable |
https://grants.nih.gov/grants/guide/pa-files/PA-20-145.html |
| 56 |
Planning
Grant for Global Infectious Disease Research Training Program (D71 No
Clinical Trials Allowed) |
This
Funding Opportunity Announcement (FOA) encourages applications for a planning
grant from institutions in low- and middle-income countries (LMICs) to 1.)
Design a Global Infectious Disease (GID) Research Training Program in
collaboration with U.S. collaborators and 2.) Strengthen LMIC faculty and
prepare advanced courses and training resources for the program envisioned at
the LMIC institution. |
$100,000 |
2
years. |
National
Institutes of Health |
Oct
28, 2022 |
Not
applicable |
http://grants.nih.gov/grants/guide/pa-files/PAR-19-362.html |
| 57 |
Notice
of Intent to Publish a Funding Opportunity Announcement for the Center for
Rapid Surveillance of Tobacco (CRST) to Assess Changes in Use Behaviors,
Product Marketing, and the Marketplace (U01 Clinical Trial Optional) |
This
Funding Opportunity Announcement (FOA) is seeking (U01) applications for
a Center for Rapid Surveillance of Tobacco (CRST) to support time-sensitive
data acquisition strategies, data harmonization, data synthesis and analysis,
and reporting activities on emerging and current tobacco use across the
United States. |
$3.8 million |
five
years. |
NIH |
May,
2022 |
Not
Applicable |
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-175.html |
| 58 |
The
USAID Global Health Broad Agency Announcement for Research and Development
(2018) |
This
Broad Agency Announcement (BAA) seeks opportunities to co-create, co-design,
co-invest, and collaborate in the research, development, piloting, testing,
and scaling of innovative, practical and cost-effective interventions to
address the most pressing problems in global health. |
not specified |
Not
specified |
United
States Agency for International Development (USAID) |
May
30, 2022 |
Not
applicable |
https://govtribe.com/opportunity/federal-contract-opportunity/the-usaid-global-health-broad-agency-announcement-for-research-and-development-2018-globalhealthbaa2018 |
| 59 |
Strategic
Alliances for Medications Development to Treat Substance Use Disorders
(R01Clinical Trial Optional) |
The
purpose of this Funding Opportunity Announcement (FOA) is to support research
that advances compounds towards FDA approval by leveraging NIDA funds with
the strengths and resources of outside organizations, such as for-profit
and not-for-profit entities, including academic institutions, pharmaceutical
and biotechnology companies, private and public foundations, and small
businesses. |
USD 3,000,000 |
3
years. |
NIH |
May
1, 2022, September 1, 2022 |
30
days prior to submission |
https://grants.nih.gov/grants/guide/pa-files/PAR-19-318.html |
| 60 |
Alexander
Gralnick Research Investigator Prize |
The
American Psychological Foundation provides financial support for innovative
research and programs that enhance the power of psychology to elevate the
human condition and advance human potential both now and in generations to
come |
USD 20,000 |
Not
specified |
APF |
May
1, 2022 |
None |
https://www.apa.org/apf/funding/gralnick |
| 61 |
Research
Project Grant (Parent R01 Clinical Trial Required) |
The
NIH Research Project Grant supports a discrete, specified, circumscribed
project in areas representing the specific interests and competencies of the
investigator(s). This Parent Funding Opportunity Announcement requires that
at least 1 clinical trial be proposed. The proposed project must be related
to the programmatic interests of one or more of the participating NIH
Institutes and Centers (ICs) based on their scientific missions. |
Budgets are not limited |
5
years |
NIH |
May
07, 2023 |
Not
applicable |
https://grants.nih.gov/grants/guide/pa-files/pa-20-183.html |
| 62 |
NIH
Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
The
NIH Research Project Grant supports a discrete, specified, circumscribed
project in areas representing the specific interests and competencies of the
investigator(s). The proposed project must be related to the programmatic
interests of one or more of the participating NIH Institutes and Centers
(ICs) based on their scientific missions. |
Budgets are not limited |
5
years |
NIH |
May
07, 2023 |
Not
applicable |
https://grants.nih.gov/grants/guide/pa-files/PA-20-185.html |
| 63 |
Achieving
Tissue Robustness Through Harnessing Immune System Plasticity (R21 Clinical
Trial Not Allowed) |
This
funding opportunity announcement (FOA) encourages state-of-the-art,
systematic research approaches to elucidate the role of immune system
plasticity in health and in the pathogenesis of dental, oral, and
craniofacial (DOC) diseases. This FOA encourages applications that will seek
to determine mechanisms underlying the ability or inability of the immune
system to dynamically maintain its functional role against internal and
external perturbations. |
$275,000 |
2
years |
NIH |
May
07, 2022 |
Not
Applicable |
https://www.grants.gov/web/grants/search-grants.html |
| 64 |
Novel
RNAs in Virology (including HIV) and Immune Regulation: Basic Science and
Therapeutic Discovery (R21 Clinical Trial Not Allowed) |
The
purpose of this Funding Opportunity Announcement (FOA) is to support basic
science research, from early exploratory studies to therapeutic discovery and
development, in novel biologically active viral and/or host RNAs involved in
virology (including HIV biology) and immune regulation. |
$275,000 |
2
years |
NIH |
May
07, 2022 |
Not
Applicable |
https://grants.nih.gov/grants/guide/pa-files/PA-19-237.html |
| 65 |
Academic-Industrial
Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01
Clinical Trial Optional) |
he
purpose of this Funding Opportunity Announcement (FOA) is to stimulate
translation of scientific discoveries and engineering developments in
imaging, data science and/or spectroscopic technologies into methods or tools
that address contemporary problems in understanding the fundamental biology,
potential risk of development, diagnosis, treatment, and/or disease status
for cancer or other disease. |
Not limited |
Not
specified |
NIH |
June
5th 2022. |
Not
applicable |
https://www.fundsbeeline.com/Funding/view_opportunity/13496/OPP017310.html |
| 66 |
Early
Stage Testing of Pharmacologic or Device-based Interventions for the
Treatment of Mental Disorders (R61/R33 Clinical Trial Required) |
The
purpose of this FOA is to support the early stage testing of pharmacologic
interventions with novel mechanisms of action or device-based interventions
for the treatment of symptoms or domains of altered functions in individuals
with mental illness (e.g., schizophrenia, depression, autism, obsessive
compulsive disorder, anxiety, bipolar disorder). |
not limited |
5
years |
NIH |
June
15, 2022 |
30
days prior to the application due date |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-137.html |
| 67 |
Lipids
in Brain Aging and Alzheimer’s Disease (AD) and its Related Dementias (ADRD)
(R01 Clinical Trial Not Allowed) |
The
goal of this Funding Opportunity Announcement (FOA) is to support
research addressing critical knowledge gaps in our understanding of how
lipids contribute to vulnerability and resilience to brain aging and
Alzheimer’s disease (AD) and its related dementias (ADRD), including
research addressing how: 1) lipid droplets affect brain aging and AD,
including whether their accumulation is pathological or protective; (2) the
periphery interacts with lipids in the aging brain, including whether these
could be targets for future biomarkers; (3) APOE and lipid-mediated signaling
influence brain aging and AD/ADRD progression; and (4) myelin lipids and
their signaling contribute to brain aging and AD/ADRD. |
$500,000 |
5
years |
NIH |
June
14, 2022 |
May
15, 2022 |
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-009.html |
| 68 |
HEAL
Initiative: Planning Studies for Initial Analgesic Development Initial
Translational Efforts [Small Molecules and Biologics] (R34 Clinical Trial Not
Allowed) |
The
goal of this funding opportunity announcement (FOA) is to solicit Initial
Analgesic Development R34 applications that propose 2-year
exploratory/planning awards that are expected to enable a future application
for RFA-NS-21-015 |
$500, 000 per year |
2
years |
NIH |
June
09, 2022 |
30
days prior to the application due date |
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-016.html?utm_medium=email&utm_source=govdelivery |
| 69 |
International
Research in Infectious Diseases (R01 Clinical Trial Not Allowed) |
The
purpose of this Funding Opportunity Announcement (FOA) is to invite
applications for support of high-priority, regionally relevant infectious
disease research by international investigators in resource-constrained
countries. |
$125,000 per year |
5
years |
National
Institute of Allergy and Infectious Diseases (NIAID) |
July
15 2022 |
30
days prior to the application due date |
https://grants.nih.gov/grants/guide/pa-files/PAR-20-108.html |
| 70 |
Family
Planning and Reproductive Health Methods APS |
The
purpose of this APS is to support the research, development, and introduction
of technologies and approaches that better meet the needs of women and girls
as their sexual and reproductive health concerns change over time |
$80,000,000 |
Not
specified |
Agency
for International Development |
Jan
14, 2023 |
Not
Applicable |
https://www.grants.gov/web/grants/view-opportunity.html?oppId=215873 |
| 71 |
Four-year
PhD Studentships in Science |
This
scheme offers graduates outstanding training in scientific research. |
£88756 |
4
years |
Chosen
programme |
Depends
on the programme |
Not
applicable |
https://wellcome.org/grant-funding/schemes/four-year-phd-programmes-studentships-basic-scientists |
| 72 |
Master’s
Studentships in Humanities and Social Science |
This
scheme enables researchers to undertake humanities or social science Master’s
courses in any area of health. |
£16,000 |
1
year |
Chosen
programme |
Depends
on the programme |
Not
applicable |
https://wellcome.org/grant-funding/schemes/masters-studentships-humanities-and-social-science |
| 73 |
Global
Infectious Disease Research Training Program (D43 Clinical Trial Optional) |
FIC
will support research-training programs that focus on major endemic or
life-threatening emerging infectious diseases, neglected tropical diseases,
infections that frequently occur as co-infections in HIV infected individuals
or infections associated with non-communicable disease conditions of public
health importance in LMICs. |
$230,000 per year |
5
years. |
NIH |
August
3, 2022 |
30 days prior to the application due
date |
https://grants.nih.gov/grants/guide/pa-files/PAR-20-229.html |
| 74 |
NIDA
Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research
(DP1, Clinical Trial Optional) |
This Award Program for HIV/AIDS Research
supports exceptionally creative scientists, who propose high-impact research
that will open new areas of HIV/AIDS research in the context of Substance Use
Disorders (SUD) and/or lead to new avenues for prevention and treatment of
HIV/AIDS in people who use drugs (PWUD). |
$700,000 per year |
5
years. |
National
Institute on Drug Abuse (NIDA) |
August
15, 2022 |
30
days prior to the application due date |
https://grants.nih.gov/grants/guide/pa-files/PAR-20-221.html |
| 75 |
Basic
Education Quality Advancement Addendum No. 72051921R00002 to Higher Education
for Leadership, Innovation, and Exchange (HELIX) New Partnerships Initiative
(NPI) Annual Program Statement Number (APS) No. 7200AA20APS00009 |
Through
this Basic Education Quality Advancement Addendum, USAID/El Salvador aims to
engage locally based new and underutilized partners to expand and amplify the
Agency’s work through and with higher education. NPI seeks to support the
partner countries’ achievement of sustainable and resilient results, and
catalyze more effective partnering for impact. |
$25,000,000 |
five
(5) years. |
El
Salvador USAID-San Salvador |
April
29, 2022 |
Not
Applicable |
https://www.grants.gov/web/grants/view-opportunity.html?oppId=333216 |
| 76 |
Fostering
balanced brain circulation – ERA Fellowships |
Fellowships
should be provided to excellent researchers, undertaking cross-border
mobility either to or between the EU Member States or Horizon Europe
Associated Countries. Applications are expected to be made jointly by the
researcher together with a beneficiary in the academic or non-academic sector
located in a Widening Country. |
EURO 8,000,000 |
Not
specified |
European
Commission |
29
September 2022. |
Not
applicable |
https://www.fundsbeeline.com/Funding/view_opportunity/16169/OPP020478.html |
| 77 |
Direct
renewable energy integration into process energy demands of the chemical
industry |
Pursued
technology developments are expected to directly target renewable energy
integration into process energy demands of the chemical industry beyond
electricity (targeting e.g. electrochemical potential of artificial
photosynthesis to chemical reduction processes and/or e.g. direct solar
thermochemical conversion) and should improve GHG balance and sustainability
of the targeted process. |
EURO 10,000,000 |
Not
specified |
European
Commission |
27
October 2022. |
Not
applicable |
https://www.fundsbeeline.com/Funding/view_opportunity/16042/OPP020332.html |
| 78 |
Demonstration
of complete value chains for advanced biofuel and non-biological renewable
fuel production |
Proposals
should demonstrate innovative and cost-effective sustainable value chains for
advanced biofuels or synthetic renewable fuels of non-biological origin
(other than for hydrogen as a final product), over the entire cycle from
feedstock to end-use. |
EURO 20,000,000 |
Not
specified |
European
Commission |
27
October 2022. |
Not
applicable |
https://www.fundsbeeline.com/Funding/view_opportunity/16045/OPP020334.html |
| 79 |
Higher
Education for Leadership, Innovation, and Exchange (HELIX), A New Partnership
Initiative (NPI) Agency for International Development |
HELIX
aims to improve partner country higher education individual, institutional,
and organizational capacity for change by supoorting opportunities for
partnerships, scholarships, exchanges, fellowships, internships,
apprenticeships, work based learning, research, communities of practice and
other relevant forms of capacity development and change management |
$1,000,000 -$60,000,000 |
5
years |
Agency
for International Development (USAID) |
2
April 2023 depending on released Addenda |
None |
https://www.grants.gov/web/grants/view-opportunity.html?searchOppId=326056&tabId=relatedDocumentsTab&origin=vgo-subscribe |
| 80 |
Options
for Pregnancy Termination Innovation Initiative (“OPTions
Initiative”) |
We
are excited to announce the initiative has launched its third round of
funding! Seed grants of up to $250,000 CAD are available for innovations that
seek to test and develop:New or improved approaches to increasing early access to existing pregnancy
termination products and services in low- and middle-income countries,
or
Next-generation methods of pregnancy termination, menses induction or
conception interruption |
$250,000 CAD |
Not
specified |
Grand
Challenges Canada |
Next generation methods applications -Rolling basis until December 31,
2022, |
Not
applicable |
https://www.grandchallenges.ca/funding-opportunities/ |
| 81 |
Innovation
Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic
Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial
Not Allowed) |
This
funding opportunity announcement (FOA) provides funding to conduct
pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate
that proposed therapeutic agent(s) have sufficient biological activity to
warrant further development to treat neurological or neuromuscular disorders
that fall under the NINDS mission. |
USD 499,000 per year |
3
years |
NIH |
20
June 2023 |
Not
applicable |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-122.html |
| 82 |
NIH
Exploratory/Developmental Research Grant Program (Parent R21 Basic
Experimental Studies with Humans Required) |
The
NIH Exploratory/Developmental Grant supports exploratory and developmental
research projects by providing support for the early and conceptual stages of
these projects |
USD 275,000 |
2
years |
NIH |
16
February 2023 |
Not
applicable |
https://www.fundsbeeline.com/Funding/view_opportunity/2318/OPP003263.html |
| 83 |
Tobacco
Regulatory Science (R01 Clinical Trial Optional) |
The
purpose of this Funding Opportunity Announcement (FOA) is to invite R01
applications to support biomedical and behavioral research that will provide
scientific data to inform regulation of tobacco products to protect public
health. |
$500,000 |
Not
specified |
NIH |
14
December 2022 |
60
days prior to the application due date |
https://www.fundsbeeline.com/Funding/view_opportunity/13489/OPP017303.html |
| 84 |
2D
materials-based devices and systems for biomedical applications (RIA) |
Proposals
should build on the multi-functionality allowed by 2DMs and demonstrate the
advantages of combining e.g. biocompatibility, chemical stability,
(bio-)sensing and actuating, and integration with flexible electronic
technologies, in addition to versatile surface chemistry (for interface with
biology) to allow continuous health monitoring and built-in pharmacological
interventions. |
EURO 6,000,000 |
not
specified |
European
Commission |
16
November 2022 |
Not
applicable |
https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-cl4-2022-digital-emerging-02-19;callCode=HORIZON-CL4-2022-DIGITAL-EMERGING-02;freeTextSearchKeyword=;matchWholeText=true;typeCodes=1;statusCodes=3109 |
| 85 |
MSCA
Doctoral Networks 2022 |
These
doctoral programmes will respond to well-identified needs in various R&I
areas, expose the researchers to the academic and non-academic sectors, and
offer training in research-related, as well as transferable skills and
competencies relevant for innovation and long-term employability (e.g.
entrepreneurship, commercialization of results, Intellectual Property Rights,
communication |
EURO 427,276,125 |
Not
specified |
European
Commission |
15
November 2022 |
Not
applicable |
https://www.fundsbeeline.com/Funding/view_opportunity/16171/OPP020480.html |
| 86 |
Clinical
Trial Readiness for Functional Neurological Disorders (U01 Clinical Trial
Optional) |
This
funding opportunity invites researchers to submit prospective clinical
projects that address critical needs for clinical trial readiness in FNDs |
Application budgets are not limited |
5
years |
NIH |
5
May 2022 |
30
days prior to application due date. |
https://grants.nih.gov/grants/guide/pa-files/PAR-22-053.html |
| 87 |
Advancing
communication strategies to support future HIV vaccine use (R21 Clinical
Trial Optional) |
The
National Institutes of Health (NIH) is inviting applications for this
Research Project Grant. This Funding Opportunity Announcement (FOA) invites
applications for Research Project Grants (R21) that will advance novel health
communication research designed to inform and support the acceptance and
uptake of future vaccines that protect against HIV. |
USD 275,000 |
2
years |
NIH |
30
April 2022 |
30
days prior to application due date |
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-171.html |
| 88 |
Urgent
Award: COVID-19 Mental Health Research (R01 Clinical Trial Required) |
This
Funding Opportunity Announcement (FOA) aims to address urgent, time-sensitive
mental health research questions related to COVID-19, including broader
secondary impacts of the pandemic as well as research on the intersection of
mental health, COVID-19, and HIV. Research supported will improve public
health in the near term by informing responses to the current pandemic
through rapid acceleration of research to address access, reach, delivery,
effectiveness, scalability and sustainability of health assessments and
interventions to respond to new and worsening mental illness and HIV-related
outcomes among those who experience COVID-19 as well as the broader
population impacted by the pandemic. All research is anticipated to focus on
particularly vulnerable populations based on existing evidence of increased
mental health symptoms and illness and preexisting health disparities. |
$750,000 direct costs per year |
3
years |
NIH |
April
25, 2022, August 25, 2022, December 23, 2022 |
30
days prior to the application due date(s) |
https://grants.nih.gov/grants/guide/pa-files/PAR-22-112.html |
| 89 |
Urgent
Award: COVID-19 Mental Health Research (R01 Clinical Trial Optional) |
This
Funding Opportunity Announcement (FOA) aims to address urgent, time-sensitive
mental health research questions related to COVID-19, including broader
secondary impacts of the pandemic as well as research on the intersection of
mental health, COVID-19, and HIV. Research supported will improve public
health in the near term by informing responses to the current pandemic
through 1) understanding mechanisms by which mental illness impacts
SARS-CoV-2 morbidity and mortality, 2) exploring how COVID-19 contributes to
incident mental illness or HIV-outcomes, 3) identifying modifiable targets
uniquely or robustly implicated in the pandemic that are relevant to new and
worsening mental illness, and 4) conducting mechanistic trials probing
biological or behavioral processes of those targets that may be pursued in
future mental health therapeutic development. Research is anticipated to be
informed by and directed towards vulnerable populations based on evidence of
preexisting and worsened health disparities. |
$750,000 direct costs per year |
3
years |
NIH |
April
25, 2022, August 25, 2022, December 23, 2022 |
31
days prior to the application due date(s) |
https://grants.nih.gov/grants/guide/pa-files/PAR-22-113.html |
| 90 |
NEI
Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial
Not Allowed) |
This
Funding Opportunity Announcement (FOA) encourages applications from
institutions/organizations that propose to conduct vision-related secondary
data analyses utilizing existing database resources. Applications may be
related to, but must be distinct from, the specific aims of the original data
collection. The NEI supports an extensive portfolio of clinical trials and
large-scale epidemiologic research projects wherein numerous data collection
activities are required to meet each project’s specific aims. The resultant
wealth of data generated by these studies often provides unique,
cost-effective opportunities to investigate additional research questions or
develop new analytical approaches secondary to a project’s
originally-intended purpose. Data are not limited to those collected under
NEI support, but such data are of the highest programmatic interest. The
purpose of this FOA is for secondary data analysis using existing data sets
from vision-related clinical trials, epidemiologic, and other clinical
research studies. This FOA may be used to develop new statistical
methodologies or test hypotheses using existing data, but this FOA must not
be used to support the collection of new data |
USD 275,000 |
2
years |
National
Institute of Health (NIH) |
June
16, 2022, October 16, 2022, February 16, 2023 |
Not
Applicable |
https://grants.nih.gov/grants/guide/pa-files/PAR-22-141.html |
| 91 |
International
Research Ethics Education and Curriculum Development Award (R25 Clinical
Trial Not Allowed) |
The
NIH Research Education Program (R25) supports research education activities
in the mission areas of the NIH. The overarching goal of this R25
program is to support “the ethics of” educational activities that
foster a better understanding of biomedical, behavioral and clinical research
and its implications. (The overarching goal of this R25 program is to support
educational activities that foster a better understanding of “the ethics
of” biomedical, behavioral and clinical research and its implications.) |
USD 230,000 per year |
5
years |
National
Institute of Health (NIH) |
June
07, 2022, June 06, 2023, June 06, 2024 |
07/05/2022,
May 6, 2023, May 6, 2024 |
https://grants.nih.gov/grants/guide/pa-files/PAR-22-118.html |
| 92 |
Translational
Research in Maternal and Pediatric Pharmacology and Therapeutics |
The
purpose of this funding opportunity announcement (FOA) is to encourage
applications that will perform basic, translational and clinical research to
(1) advance the understanding of underlying mechanisms of drug action; (2)
discover and develop novel therapeutics; (3) enhance the usage of existing
drugs or drug repurposing for safer and more effective treatment for pregnant
women, lactating women, neonates and children. The overall goal is to improve
drug safety and efficacy for maternal and pediatric precision therapeutics. |
$275,000. |
2
years |
NIH |
August 10, 2022, December 9, 2022. |
30
days prior to application receipt date |
https://grants.nih.gov/grants/guide/pa-files/PAR-20-299.html |
| 93 |
Clinical
Characterization of Cancer Therapy-induced Adverse Sequelae and
Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) |
This
FOA supports basic, translational, and/or clinical research projects that
seek to identify the mechanisms of therapy-induced adverse sequelae,
clinically characterize the adverse sequelae, or translate the mechanistic
understanding into therapeutic approaches to prevent or minimize the
development of long-term sequelae. |
Application budgets are not limited |
5
years |
NIH |
June
05, 2022, October 05, 2022 |
30
days prior to the application due date |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-329.html |
| 94 |
Agroecological
approaches for sustainable weed management |
A
successful proposal should support the farm to fork’s strategy objective of a
transition to a fair, healthy and resilient European agriculture, notably its
objective to promote agroecology, and the target to reduce the overall use
and risk of chemical pesticides, by unfolding the potential of agroecology to
provide alternative weeding strategies that reduce or eliminate the use of
pesticides used as herbicides. |
EURO 14,500,000 |
Not
specified |
European
Commission |
06-Sep-22 |
Not
applicable |
https://www.fundsbeeline.com/Funding/view_opportunity/16187/OPP020497.html |
| 95 |
Dyadic
Interpersonal Processes and Biopsychosocial Outcomes (R01 – Basic
Experimental Studies with Humans) |
This
funding opportunity announcement (FOA) invites basic and/or methodological
research projects that illuminate and/or measure independent and
interdependent health-related effects within dyads across relationships and
settings. For the purpose of this FOA, a dyad is a unit of two
individuals whose interactions and influences on one another are nested
within larger social contexts and networks. |
budgets are not limited |
5
years |
NIH |
March
05, 2023 |
Not
applicable |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-280.html?utm_medium=email&utm_source=govdelivery |
| 96 |
Dyadic
Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not
Allowed) |
This
funding opportunity announcement (FOA) invites basic and/or methodological
research projects that seek to illuminate or measure independent and
interdependent health-related effects within dyads. For the purpose of this
FOA, a dyad is a unit of two individuals whose interactions and
influences on one another are nested within larger social contexts and
networks. Both animal and human subjects research projects are welcome |
Budget not limited |
5
years |
NIH |
February
05, 2023 |
Not
applicable |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-281.html?utm_medium=email&utm_source=govdelivery |
| 97 |
HIV-associated
Non-Communicable Diseases Research at Low- and Middle-Income Country
Institutions (R21 Clinical Trial Optional) |
The
goals of this program are to support locally relevant research in critical
areas of HIV-associated non-communicable diseases (NCDs) at Low- and
Middle-Income Country (LMIC) Institutions, to enhance research capacity, and
to build a network of researchers both within and across LMICs to address
this critical burden |
$275,000 per year |
2
years |
NIH |
December
08, 2022 |
November
8, 2021 |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-246.html |
| 98 |
HEAL
Initiative: Planning Studies for Initial Analgesic Development [Small
Molecules and Biologics] (R61 Clinical Trial Not Allowed) |
These
R61 awards will support the building of a research team to collect initial
data and recruit additional collaborators. |
may not exceed $500,000 per year |
2
years |
NIH |
June
09, 2022, October 11, 2022, June 09, 2023, October 10, 2023. |
30
days prior to application due date. |
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-029.html?utm_medium=email&utm_source=govdelivery |
| 99 |
Chronic,
Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty
International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial
Optional) |
The proposed institutional research training
program is expected to sustainably strengthen the NCD research capacity of
the LMIC institutions, and to train in-country experts to develop and conduct
research on NCDs across the lifespan, |
$230,000 per year |
5
years |
NIH |
July
13, 2022, July 13, 2023 |
30
days before receipt date |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-230.html?utm_medium=email&utm_source=govdelivery |
| 100 |
Blueprint
Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and
Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial
Optional) |
This
Funding Opportunity Announcement (FOA) supports preclinical discovery and
development of potential therapeutic Biotechnology Products and Biologics |
Application budgets are not limited |
2-4
years |
NIH |
August
09, 2022 |
30
days prior to the application due date |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-163.html?utm_medium=email&utm_source=govdelivery |
| 101 |
HEAL
Initiative: Team Research for Initial Translational Efforts in Non-addictive
Analgesic Therapeutics Development (U19 Clinical Trial Not Allowed) |
The
goal of this FOA is to support team-based research projects to develop
assays, screening and early optimization work to develop a non-addictive
therapeutic to treat pain |
$1.5 million per year |
5
years |
NIH |
June
9, 2022, October 11, 2022, June 9, 2023, and October 10, 2023 |
30
days prior to the application due date |
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-015.html?utm_medium=email&utm_source=govdelivery |
| 102 |
BRAIN
Initiative: Optimization of Transformative Technologies for Recording and
Modulation in the Nervous System (U01 Clinical Trials Not Allowed) |
This
FOA seeks applications to optimize existing or emerging technologies through
iterative testing with end users |
Not Specified |
4
years. |
National
Institute of Health (NIH) |
May
02, 2022, October 28, 2022, May 01, 2023, October 27, 2023. |
60
days prior to the receipt date |
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-027.html |
| 103 |
BRAIN
Initiative: New Concepts and Early-Stage Research for Recording and
Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) |
to
understand how electrical and chemical signals code information in neural
circuits and give rise to sensations, thoughts, emotions and actions |
not specified |
3years |
NIH |
May
2, 2022; October 28, 2022, May 1, 2023, October 27, 2023 |
Not
applicable |
https://grants.nih.gov/grants/guide/rfa-files/RFA-EY-21-001.html |
| 104 |
Fertility
Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed) |
The
purpose of this FOA is to support exploratory/developmental research that
explores the premise that fertility status can be a marker for overall
health. Chronic conditions such as cancer, diabetes, and obesity can impair
fertility; however, less is known about the extent to which fertility status
can impact or act as a marker for overall health. |
$275,000 |
2
years |
NIH |
Oct
19, 2022, Jun 19, 2023 |
30
days prior to the application due date |
https://grants.nih.gov/grants/guide/pa-files/PAR-20-282.html# |
| 105 |
Global
Infectious Disease Research Administration Development Award for Low-and
Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) |
This
Funding Opportunity Announcement (FOA) is to invite applications from
research institutions in low- to middle-income countries (LMIC) to provide
senior administrators from these institutions with advanced training in the
management of NIH grants. |
up to $100,000 per 18 months |
may
not exceed 18 months. |
NIH |
July
28, 2022, July 28, 2023 |
30 days prior to the application due
date |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-037.html |
| 106 |
New
Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01
Clinical Trial Required) |
NIDA
is interested in research that addresses gaps related to the delivery of
comprehensive, integrated health services to include the full continuum of
HIV/AIDS services, addiction prevention and treatment services, and primary
care services, with a goal of improving the coordination of care, and
improving health outcomes related to HIV and SUD in the US |
Application budgets are not limited |
5
years. |
National
Institute on Drug Abuse (NIDA) |
August
11, 2022, November 18, 2022, August 11, 2023 |
Not
Applicable |
https://grants.nih.gov/grants/guide/pa-files/PAR-20-273.html |
| 107 |
Secondary
Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep
Disorders (R21 Clinical Trial Not Allowed) |
The
goal of this funding opportunity is to stimulate the use of existing human
datasets for well-focused secondary analyses to investigate novel scientific
ideas or new models, systems, tools, methods, or technologies that have the
potential for significant impact on biomedical or biobehavioral research in
areas relevant to the NHLBI mission. |
$75,000 per year |
2 years. |
NIH |
October
28, 2022 |
Not
Applicable |
https://grants.nih.gov/grants/guide/pa-files/PAR-20-078.html |
| 108 |
NEI Vision Research Epidemiology Grant (UG1
Clinical Trial Not Allowed) |
The
National Eye Institute (NEI) supports investigator-initiated, complex,
multi-center and other high resource risk epidemiologic studies under the
cooperative agreement mechanism, UG1 activity code. Specifically, the purpose
of this Funding Opportunity Announcement (FOA) is to support new and
innovative ocular epidemiology research. |
budgets are not limited |
5
years |
NIH |
May
25, 2022, September 25, 2022 |
Not
Applicable |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-204.html |
| 109 |
Detection
of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed) |
The
purpose of this Funding Opportunity Announcement (FOA) is to support
collaborative, interdisciplinary early-stage research to inform the
development of innovative rapid, sensitive, simple, and cost-effective
diagnostic technologies that will enable HIV self-testing during the earliest
phases of acute infection or during viral rebound. |
$500,000 per year |
5
years |
NIH |
March
17, 2023 |
30
days prior to the application due date |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-070.html |
| 110 |
The
HIV Vaccine Research and Design (HIVRAD) Program |
The
purpose of this Funding Opportunity Announcement (FOA) is to support
multi-component, multi-disciplinary projects that address scientific
questions relevant to AIDS prophylactic vaccine discovery research. Extensive
evaluation of vaccine concepts in non-human primate models may be included. |
$2.5M per year |
5
years |
NIH |
March
15, 2023 |
30
days prior to the application due date |
https://grants.nih.gov/grants/guide/pa-files/par-21-024.html |
| 111 |
Development
& Testing of Novel Interventions to improve HIV Prevention, Treatment,
and Program Implementation for People Who Use Drugs (R34 Clinical Trial
Required) |
This
Funding Opportunity Announcement (FOA) encourages formative research,
intervention development, and pilot-testing of interventions for people who
use drugs. Primary outcomes of interest include the feasibility,
tolerability, acceptability and safety of novel or adapted interventions that
target HIV prevention, treatment or services research. |
$450,000 |
3
years |
NIH |
May
07, 2022 |
Not
applicable |
https://grants.nih.gov/grants/guide/pa-files/PA-21-205.html |
| 112 |
Pediatric
Immune System – Ontogeny and Development (INTEND) (R01 Clinical Trial Not
Allowed) |
The
purpose of this Funding Opportunity Announcement (FOA) is to correlate immune
system development patterns between two or more age groups – neonates,
infants, and children and adolescents and further understand the impact of
infectious diseases, microbiome and environmental factors on the ontogeny and
development of the pediatric immune system, from birth, transitioning into
adolescence and adulthood with the focus of impact during pregnancy and
post-natal period. |
$400,000 |
4
years |
NIH, Eunice Kennedy Shriver
National Institute of Child Health and Human Development (NICHD) |
October
05, 2022, February 05, 2023 |
Not
Applicable |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-248.html |
| 113 |
HEAL
Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules
and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) |
The
goal of the program is to accelerate the optimization and development of
promising small molecule and biologic hits/leads to Phase I clinical trials
and readiness for the Early Phase Pain Investigation Clinical Network
(EPPIC-Net) https://heal.nih.gov/research/clinical-research/eppic-net or
other Phase II clinical studies. |
Budget is not limited |
5
years |
NIH |
June
15, 2022 |
30
days prior to receipt date. |
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-010.html |
| 114 |
Development
and Testing of Novel Interventions to improve HIV Prevention, Treatment, and
Program Implementation for People Who Use Drugs (R34 Clinical Trial Required) |
his
Funding Opportunity Announcement (FOA) encourages formative research,
intervention development, and pilot-testing of interventions. Primary
scientific areas of focus include the feasibility, tolerability,
acceptability and safety of novel or adapted interventions that target HIV
prevention, treatment or services research for people who use drugs. For the
purposes of this FOA, “intervention” may include behavioral,
social, or structural approaches, as well as combination biomedical and behavioral
approaches that prevent the acquisition and transmission of HIV infection, or
improve clinical outcomes for persons living with HIV. |
$450,000 |
3
years |
NIH |
May
07, 2022 |
Not
Applicable |
https://grants.nih.gov/grants/guide/pa-files/PA-21-205.html |
| 115 |
Computationally-Defined
Behaviors in Psychiatry (R21 Clinical Trial Optional) |
This
Funding Opportunity Announcement (FOA) solicits applications for research
projects that will apply computational approaches to develop parametrically
detailed behavioral assays across mental-health relevant domains of function. |
up to $275,000 |
2
years |
NIH |
October
1, 2022; October 1, 2023 |
November
01, 2021,November 01, 2022, November 01, 2023 |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-264.html |
| 116 |
Mobile
Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 –
Clinical Trial Optional) |
The
purpose of this Funding Opportunity Announcement (FOA) is to encourage
exploratory/developmental research applications that propose to study the
development, validation, feasibility, and effectiveness of innovative mobile
health (mHealth) interventions or tools specifically suited for low- and
middle-income countries (LMICs) that utilize new or emerging technology,
platforms, systems, or analytics |
R21 – $125,000 per year R33 – $200,000
per year |
R21 – 2 years R33-3 years |
NIH |
November
15, 2021 November 15, 2022 |
October
16, 2021; October 15, 2022 |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-303.html |
| 117 |
Small
Grants for New Investigators to Promote Diversity in Health-Related Research
(R21 Clinical Trial Optional) |
The
purpose of this Funding Opportunity Announcement (FOA) is to provide support
for new investigators from diverse backgrounds, including from groups
nationally underrepresented in biomedical research, to conduct small research
projects in the scientific mission areas of the National Institute of
Diabetes and Digestive and Kidney Diseases (NIDDK) and participating
Institutes and Centers. |
$125,000 per year |
3
years. |
NIH |
June
16, 2022 |
Not
Applicable |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-313.html |
| 118 |
Utilizing
Invasive Recording and Stimulating Opportunities in Humans to Advance Neural
Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial
Optional) |
The
purpose of this Funding Opportunity Announcement (FOA) is to encourage
applications to pursue invasive neural recording studies focused on mental
health-relevant questions. |
$275,000 |
2
years. |
NIH |
June
16, 2022 |
Not
Applicable |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-288.html |
| 119 |
Innovative
Mental Health Services Research Not Involving Clinical Trials (R01 Clinical
Trials Not Allowed) |
The
purpose of this Funding Opportunity Announcement (FOA) is to encourage
innovative research that will inform and support the delivery of
high-quality, continuously improving mental health services to benefit the
greatest number of individuals with, or at risk for developing, a mental
illness. |
Application budgets are not limited |
5
years |
NIH |
June
05, 2022, October 5, 2022, February
05, 2023 |
30
days prior to the application due date |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-316.html |
| 120 |
BRAIN
Initiative: New Technologies and Novel Approaches for Recording and
Modulation in the Nervous System (R01 Clinical Trial Not Allowed) |
This
FOA seeks exceptionally creative approaches to address major challenges
associated with recording and modulating CNS activity, at or near cellular
resolution, at multiple spatial and/or temporal scales, in any region and
throughout the entire depth of the brain. It is expected that the proposed
research may be high-risk, but if successful, could profoundly change the
course of neuroscience research. |
Application budgets are not limited |
3
years. |
NIH |
May
02, 2022, October 28, 2022 |
60
days prior to the receipt date. |
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-026.html |
| 121 |
Blueprint
MedTech Translator (UG3/UH3 – Clinical Trial Optional) |
The
purpose of this Funding Opportunity Announcement (FOA) is to encourage
investigators to pursue translational activities and clinical feasibility
studies to advance the development of therapeutic, and diagnostic devices for
disorders that affect the nervous or neuromuscular systems. |
Application budgets are not limited |
4
to 5 years |
NIH |
June
20, 2022 |
60
days prior to the application due date. |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-315.html?utm_medium=email&utm_source=govdelivery |
| 122 |
Basic
Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed) |
This
Funding Opportunity Announcement (FOA) encourages grant applications from
investigators interested in conducting basic, mechanistic research into the
biological/genetic causes of cancer health disparities. |
$50,000 |
2
years |
NIH |
June
16, 2022 |
Not
Applicable |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-324.html |
| 123 |
Basic
Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) |
These
research project grants (R01) will support innovative studies designed to
investigate biological/genetic bases of cancer health disparities, such as
(1) mechanistic studies of biological factors associated with cancer health
disparities, including those related to basic research in cancer biology or
cancer prevention strategies, (2) the development and testing of new
methodologies and models, and (3) secondary data analyses. |
Application budgets are not limited |
5
years |
NIH |
June
05, 2022 |
Not
Applicable |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-322.html |
| 124 |
Basic
Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) |
These
awards will support pilot and feasibility studies designed to investigate
biological/genetic bases of cancer health disparities, such as (1)
mechanistic studies of biological factors associated with cancer health
disparities, (2) the development and testing of new methodologies and models,
and (3) secondary data analyses. |
$275,000 |
2
years |
NIH |
June 16, 2022 |
Not
Applicable |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-323.html |
| 125 |
High
Priority HIV and Substance Use Research (R01 Clinical Trial Optional) |
The
purpose of this Funding Opportunity Announcement (FOA) is to support high
priority research at the intersection of HIV and substance use. This FOA
invites innovative research projects with the potential to open new areas of
HIV/AIDS research and/or lead to new avenues for prevention, treatment and
cure of HIV among people who use drugs (PWUD) |
Application budgets are not limited |
5
years |
NIH |
August
15, 2022, February 15, 2023 |
30
days prior to the application due date |
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-040.html |
| 126 |
Emerging
Global Leader Award (K43 Independent Clinical Trial Not Allowed) |
The
purpose of the Fogarty Emerging Global Leader Award is to provide research
support and protected time (three to five years) to an early career research
scientist from a low- or middle-income country (LMIC) who holds a junior
faculty position at an LMIC academic or research institution, as defined by
the World Bank
(http://data.worldbank.org/about/country-classifications/country-and-lending-groups,
including “low-income,” “lower-middle-income,” and “upper-middle-income”
countries). |
Refer to other award budget information |
5
years. |
NIH |
November
3, 2022, and November 3, 2023 |
30
days before the application due date |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-252.html |
| 127 |
Emerging
Global Leader Award (K43 Independent Clinical Trial Required) |
This
Funding Opportunity Announcement (FOA) invites applications from LMIC
scientists from any health-related discipline who propose career development
activities and a research project that is relevant to the health priorities
of their country under the mentorship of LMIC and U.S. mentors. |
Refer to other award budget information |
5
years. |
NIH |
November
3, 2022, and November 3, 2023 |
30
days before the application due date |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-251.html |
| 128 |
Utilizing
the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early
Detection Research (U01 Clinical Trial Not Allowed) |
This
FOA supports a wide range of cancer research including, but not limited to,
biochemical and genetic analyses of cancer risk, as well as discovery and
validation of early detection biomarkers. The proposed research project must
involve use of PLCO biospecimens and may include other resources;
additionally, it should also take advantage of the unique characteristics of
the PLCO biospecimens. |
Application budgets are not limited |
5
years. |
NIH |
June
10, 2022, October 11, 2022 |
30
days prior to the application due date. |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-330.html |
| 129 |
AIDS-Science
Track Award for Research Transition (R03 Clinical Trial Optional) |
This
funding opportunity announcement (FOA) seeks to facilitate the entry of both
newly independent and early career investigators to the area of drug use and
use disorder research and HIV/AIDS. |
$100,000 per year |
2
years |
NIH |
May
07, 2022, September 07, 2022 |
Not
Applicable |
https://grants.nih.gov/grants/guide/pa-files/PAS-21-270.html |
| 130 |
Global
Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical
Trials Optional) |
This
Funding Opportunity Announcement (FOA) encourages grant applications for the
conduct of innovative, collaborative research projects with low- and
middle-income country (LMIC) institutions/ scientists on brain and other
nervous system function and disorders throughout life, relevant to LMICs. |
Application budgets are not limited |
5
years |
NIH |
November
15, 2022, November 15, 2023 |
30
days prior to the application due date |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-311.html |
| 131 |
Global
Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical
Trial Optional) |
This
Funding Opportunity Announcement (FOA) encourages exploratory/developmental
research grant applications, piloting innovative, collaborative research
projects with low- and middle-income country (LMIC) institutions/ scientists
on brain and other nervous system-related function and disorders throughout
life, relevant to LMICs. |
$125,000 per year |
2
years. |
NIH |
November 15, 2022, November 15, 2023 |
30
days before receipt date |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-319.html |
| 132 |
Research
on Biopsychosocial Factors of Social Connectedness and Isolation on Health,
Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans
Required) |
This
funding opportunity announcement (FOA) invites research projects that seek to
explain the underlying mechanisms, processes, and trajectories of social
relationships and how these factors affect outcomes in human health, illness,
recovery, and overall wellbeing. |
Application budgets are not limited |
5
years |
NIH |
June
21, 2023, June 21, 2024 |
Not
applicable |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-352.html |
| 133 |
Research
on Biopsychosocial Factors of Social Connectedness and Isolation on Health,
Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed) |
This
funding opportunity announcement (FOA) invites research projects that seek to
model the underlying mechanisms, processes, and trajectories of social
relationships and how these factors affect outcomes in health, illness,
recovery, and overall wellbeing. |
Application budgets are not limited |
5
years |
NIH |
June
21, 2023, June 21, 2024 |
Not
applicable |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-350.html |
| 134 |
The
role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and
Hodgkin disease (HD) development with or without an underlying HIV infection
(U01 Clinical Trial Optional) |
This
funding opportunity announcement (FOA) focuses on the role of EBV infection
on Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or
without an underlying HIV infection. |
Application budgets are not
limited |
5
years |
NIH |
December
15, 2022, December 15, 2023 |
30
days prior to the application due date |
https://grants.nih.gov/grants/guide/pa-files/PAR-21-348.html |
| 135 |
C.H.I.L.D.R.E.N!® |
The
project mission is to alleviate disease, seek cures, and ultimately improve
the quality of life of children affected with Primary Immunodeficiency
throughout the world. |
$25,000 per year |
Upto
2 years |
Jeffrey
Modell Foundation (JMF) |
Applications
are currently accepted and reviewed on a rolling basis |
None |
http://www.info4pi.org/medical/research-grants/childrenr |
| 136 |
Development
Innovation Ventures (DIV) |
(DIV) is
USAID’s open innovation program that tests and scales creative solutions to
any global development challenge. By investing in breakthrough innovations
driven by rigorous evidence, USAID impacts millions of lives at a
fraction of the usual cost. |
$200,000 – $5,000,000 |
3
years |
USAID |
No
deadline |
None |
https://www.usaid.gov/div |
| 137 |
Water
or Sanitation Challenge in Asia or Africa |
Thematic
Areas: Drinking water, Safe Water Enterprises, Safe water at point of use,
Sanitation, Toilet economy , Circular sanitation economy, Water Resources
Management, Recharge, Retention & Reuse (3R), Water efficiency |
not specified |
Not
specified |
Aqua
for All |
On-going |
None |
https://aquaforall.org/get-support/apply |
| 138 |
Peace
& Recovery Program: COVID-19 Off-Cycle Funding |
IPA’s
Peace & Recovery Program is pleased to announce that it is now accepting
off-cycle proposals, capped at $50,000, for time-sensitive research projects
and additions to research projects that study or support the COVID-19
response. |
$ 50,000 |
Not
specified |
Innovations
for Poverty Action |
Any
time |
None |
https://www.poverty-action.org/publication/peace-recovery-program-covid-19-cycle-funding |
| 139 |
AfOx
Travel Grants |
The overarching aim of the scheme is to
foster the development of new collaborations and the scheme is not intended
to be used as alternative support for already established collaborations. |
up to £5000 |
1
to 8 weeks |
Africa
Oxford initiative |
Ongoing |
None |
https://www.opportunitiesforafricans.com/africa-oxford-initiative-afox-travel-grants-2021/ |
| 140 |
Mercatus
Launches Prize Fund to Combat COVID-19 |
The
Mercatus Center at George Mason University announced today a series of prizes
through its Emergent Ventures program for innovators working to combat
COVID-19. |
Up to $100,000 |
Unavailable |
Mercatus |
Open
Year Round |
Not
applicable |
https://covid19innovationhub.org/funding/mercatus-launches-prize-fund-to-combat-covid-19 |
| 141 |
ICESCO
Prize for Fighting Novel Coronavirus (Covid-19) |
The
Prize has been earmarked by ICESCO to reward anyone who has discovered an
efficient cure or vaccine against Coronavirus. To this effect, the
Organization invites independent researchers, group of researchers or
research institutions to send their nominations |
Up to $200,000 |
Unavailable |
Islamic
World Educational, Scientific and Cultural Organization (ICESCO) |
Open
Year Round |
Not
Applicable |
https://covid19innovationhub.org/funding/icesco-prize-for-fighting-novel-coronavirus-covid-19 |
| 142 |
Expression
of Interest:
Vaccine Drug Products in alternative
primary packaging and delivery devices |
CEPI
is requesting information from vaccine developers and their vaccine
manufacturers, who are
looking to establish additional primary packaging and fill/finish capacity,
and/or are interested in
a novel delivery device that facilitates mass vaccination. |
Not Specified |
Not
Specified |
The
Coalition for Epidemic Preparedness Innovations (CEPI) |
Rolling
basis |
Not
Applicable |
https://cepi.net/wp-content/uploads/2020/11/EoI-vaccine-in-bags_text-01Mar21.pdf |
| 143 |
Grant
Funding-Fanconi Anemia Research Fund |
The
Fanconi Anemia Research Fund (FARF) seeks to fund interdisciplinary and
translational research efforts that will lead to rapid discovery and
development of therapies or strategies that treat, control, or cure Fanconi
anemia (FA). |
USD 250,000 |
1-2
years |
Fanconi
Anemia Research Fund (FARF) |
No
Deadline |
Not
Applicable |
https://www.fanconi.org/explore/apply-for-grant-funding |
| 144 |
Main
Grants |
Main
Grants are given to large, established organizations working at a regional or
national scale that can demonstrate the sustained impact of their programmes,
in the areas of to sexual and reproductive health services (SRH) and
Nutrition. |
between £50,000 and £100,000 |
1-3
years |
The
Waterloo Foundation (TWF) |
No
Deadline |
Not
Applicable |
http://www.waterloofoundation.org.uk/WorldDevelopmentAboutTheProgramme.html |
| 145 |
Brain
Tumor Research Grants |
Proposals
related to basic and translational projects that can advance understanding of
the underlying biology of the development and treatment of PLGA tumors will
be considered. |
Not specified |
Not specified |
A
Kids’ Brain Tumor Cure Foundation |
No
Deadline |
Not
Applicable |
https://akidsbraintumorcure.org/medical-research-on-childhood-brain-tumors/apply-for-a-plga-sponsored-grant/ |
| 146 |
Apply
for funding |
The
Draper Richards Kaplan Foundation seeks to dramatically improve the lives of
people and the world around us through innovative strategies, systems
changing approaches, and disrupting technologies. Our goal is to find
social entrepreneurs with dynamic ideas and nurture them at the early stages
with maximum leverage and total commitment. |
$300,000 |
3
years |
Draper
Richards Kaplan |
Open
Year Round |
Not
applicable |
https://www.drkfoundation.org/apply-for-funding/ |
| 147 |
Non-communicable
diseases risk reduction in adolescence and youth (Global Alliance for Chronic
Diseases – GACD) |
The
topic is focused on implementation research about common risk prevention
interventions targeting adolescents and youth to reduce the impact of
non-communicable diseases (NCDs) in low- and middle-income countries (LMICs)
and vulnerable populations in high-income countries (HICs). |
EURO
25,000,000 |
Not
specified |
European
Commission |
21-Apr-22 |
Not
applicable |
https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-hlth-2022-disease-07-03;callCode=HORIZON-HLTH-2022-DISEASE-07;freeTextSearchKeyword=;matchWholeText=true;typeCodes=1;statusCodes=31094501,31094502,31 |
| 148 |
Public
procurement of innovative solutions (PPI) for building the resilience of
health care systems in the context of recovery |
This
topic aims at supporting activities that are enabling or contributing to one
or several expected impacts of destination 4 “Ensuring access to innovative,
sustainable and high-quality health care”. |
EUR 30,000,000 |
Not
specified |
European
Commission |
April
21, 2022 |
Not
Applicable |
https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-hlth-2022-care-08-02 |
| 149 |
Cooperation,
synergies and networking between research infrastructures and technology
infrastructures |
The
development of the research infrastructure landscape, as well as access to
research infrastructure services, is significantly more advanced due to both
the strategic priority setting process, through the Roadmap of the European
Strategy Forum on Research Infrastructures, and the significant effort at the
EU level to open up national facilities and laboratories to international
users. |
EURO 1,500,000 |
Not
specified |
European
Commission |
April
20, 2022 |
Not
applicable |
https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-infra-2022-dev-01-02;callCode=HORIZON-INFRA-2022-DEV-01;freeTextSearchKeyword=;matchWholeText=true;typeCodes=1;statusCodes=31094501,31094502,31094503 |
